NCT02738203View on ClinicalTrials.gov

Self-Administered Lidocaine Gel for Pain Management With IUD Insertion

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

October 19, 2017

Study Completion Date

October 19, 2017

Conditions
IUD Insertion
Interventions
DRUG

Vaginal 2% Lidocaine

Patient-administered vaginal Lidocaine jelly verse surgical lubricant jelly

DRUG

Surgical Lubricant Jelly

Patient-administered vaginal surgical lubricant jelly verse Lidocaine jelly

Trial Locations (1)

94305

Stanford Gynecology Clinic, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT02738203 - Self-Administered Lidocaine Gel for Pain Management With IUD Insertion | Biotech Hunter | Biotech Hunter